Tony Hunter, Ph.D., celebrated for pioneering discoveries that inspired the development of more than 80 cancer therapies that continue to transform patient lives. New Brunswick, N.J. – Johnson & Johnson announced… Read More
At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete improvement in tissue health1. At lower doses, patients… Read More
The investment will expand RNA Technologies & Therapeutics’ operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics. Vancouver, BC – Acuitas Therapeutics, the global leader… Read More
Plans to seek regulatory approval to commence a Phase III trial in the US and Canada Vancouver, BC – Sustained Therapeutics Inc., a clinical-stage therapeutics company developing a non-opioid treatment… Read More
Series B Co-led by New Investors Amplitude Ventures and ICG MTX-474 Global Phase 2a study Initiated in Systemic Sclerosis (SSc) MTX-463 Global Phase 2a Study in Idiopathic Pulmonary Fibrosis (IPF)… Read More
